| Literature DB >> 31328398 |
Cheng Zhang1,2,3, Li Li1, Felicity Y Han1,4, Xinying Yu1,5, Xiao Tan1,5, Changkui Fu1,2, Zhi Ping Xu1, Andrew K Whittaker1,2.
Abstract
19 F magnetic resonance imaging (19 F MRI) agents capable of being activated upon interactions with cancer triggers are attracting increasing attention, although challenges still remain for precise and specific detection of cancer tissues. In this study, a novel hybrid 19 F MRI agent for pH-sensitive detection of breast cancer tissues is reported, a composite system designed by conjugating a perfluoropolyether onto the surface of manganese-incorporated layered double hydroxide (Mn-LDH@PFPE) nanoparticles. The 19 F NMR/MRI signals from aqueous solutions of Mn-LDH@PFPE nanoparticles are quenched at pH 7.4, but "turned on" following a reduction in pH to below 6.5. This is due to partial dissolution of Mn2+ from the Mn-LDH nanoparticles and subsequent reduction in the effect of paramagnetic relaxation. Significantly, in vivo experiments reveal that an intense 19 F MR signal can be detected only in the breast tumor tissue after intravenous injection of Mn-LDH@PFPE nanoparticles due to such a specific activation. Thus pH-activated Mn-LDH@PFPE nanoparticles are a potential "smart" 19 F MRI agent for precise and specific detection of cancer diseases.Entities:
Keywords: activated agents; breast cancer; contrast agents; fluorine magnetic resonance imaging; paramagnetic relaxation enhancement
Year: 2019 PMID: 31328398 DOI: 10.1002/smll.201902309
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281